Y-Intercept (HK)’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

Y-Intercept (HK)’s Portfolio DMRA Stock Details DMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,921	Closed	-$205K	–	1886
2026 Q1	$205K	Buy	+7,921	New	+$204K	﹤0.01%	1439

Y-Intercept (HK)'s DMRA Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Damora Therapeutics, Inc. Ordinary Shares (DMRA) in Q2 2026, closing a stake of 7,921 shares — an estimated $205K sold.

Y-Intercept (HK) first reported a position in DMRA in Q1 2026 and held it in 1 quarter. The position peaked at $205K in Q1 2026. 0 funds tracked by Wall St. Rank hold DMRA as of Q2 2026.

Y-Intercept (HK) reported no remaining Damora Therapeutics, Inc. Ordinary Shares position as of Q2 2026 after selling out during the quarter.
Y-Intercept (HK) sold 7,921 Damora Therapeutics, Inc. Ordinary Shares shares in Q2 2026, an estimated $205K.
Y-Intercept (HK) first reported a position in Damora Therapeutics, Inc. Ordinary Shares in Q1 2026 and held it in 1 quarter.
Y-Intercept (HK)'s Damora Therapeutics, Inc. Ordinary Shares position peaked at $205K in Q1 2026.
0 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.